{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:02:55Z","timestamp":1760079775846},"reference-count":65,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T00:00:00Z","timestamp":1402272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Paediatrics Child Health"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The development of efficacious prophylactic human papillomavirus vaccines provided an opportunity for the primary prevention of related infections and diseases. Certain oncogenic human papillomaviruses that preferentially infect the genital epithelium cause cervical cancer and a substantial proportion of anal, penile, vaginal, vulvar and oropharyngeal cancers. Following extensive clinical trials demonstrating their efficacy and safety, two vaccines have been in global use for over 6 years. This review summarises the accumulated evidence regarding their high level of efficacy, safety in population usage, reductions in genital warts, infections and cervical disease following their adoption, and facilitators and barriers to achieving high vaccination coverage. The review also discusses practical issues and frequently asked questions regarding duration of effect, vaccination of women treated for cervical disease and alternate vaccination schedules, as well as the need to review cervical screening strategies in the post\u2010 vaccination environment.<\/jats:p>","DOI":"10.1111\/jpc.12627","type":"journal-article","created":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T10:23:16Z","timestamp":1402309396000},"page":"959-965","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Human papillomavirus vaccination: Where are we now?"],"prefix":"10.1111","volume":"50","author":[{"given":"Julia ML","family":"Brotherton","sequence":"first","affiliation":[{"name":"National HPV Vaccination Program Register VCS Inc  East Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,6,9]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.083"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.115"},{"issue":"5","key":"e_1_2_12_4_1","article-title":"Updating the natural history of human papillomavirus and anogenital cancers","volume":"30","author":"Moscicki AB","year":"2012","journal-title":"Vaccine"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70096-8"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2013.08.020"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.8389"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25396"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.055"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.3870"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23764"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70080-3"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.22111"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.106"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2010.08.003"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.12.18281"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.2.13948"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.108"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1086\/597307"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70287-X"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70286-8"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61567-1"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0039-5"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5906"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.08.106"},{"key":"e_1_2_12_26_1","unstructured":"GSK Press release.GSK Cervarix\u00ae two\u2010dose schedule receives European marketing authorisation.2013. Issued: Friday 20 December 2013 London UK. Available from:http:\/\/www.gsk.com\/media\/press\u2010releases\/2013\/gsk\u2010cervarix\u2013two\u2010dose\u2010schedule\u2010receives\u2010european\u2010marketing\u2010auth.html[accessed 23 May 2014]."},{"key":"e_1_2_12_27_1","unstructured":"ABC news website.Story date 8 November 2013 Sidney Lupkin.2013. Merck doses cited in Available from:http:\/\/abcnews.go.com\/Health\/doctors\u2010call\u2010claims\u2010gardasil\u2010caused\u2010sisters\u2010infertility\u2010bogus\/story?id=20830299[accessed 23 May 2014]."},{"key":"e_1_2_12_28_1","first-page":"197","article-title":"Catching up with the catch\u2010up: HPV vaccination coverage data for Australian women aged 18\u201326 year from the National HPV Vaccination Program Register","volume":"35","author":"Brotherton JML","year":"2011","journal-title":"Commun. Dis. Intell."},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja13.10272"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis590"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2032"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-140"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60551-5"},{"key":"e_1_2_12_34_1","unstructured":"Australian Institute of Health and Welfare.2013.Cervical screening in Australia 2010\u20132011. Cancer series 76. Cat. no. CAN 72. Canberra: AIHW."},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-227"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2013.09.018"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.10.085"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit361"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.10.092"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.4645"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-13-0272"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/10810730.2011.585700"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-6405.2010.00669.x"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2013.2752"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2013.08.009"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.075"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.11.089862"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.12.037"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis489"},{"key":"e_1_2_12_50_1","unstructured":"Chief Medical Officer.Guidance on revaccination where HPV vaccine doses have been given at less than recommended minimum intervals.2009. Available from:http:\/\/www.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/cmo\u2010full\u2010advice\u2010hpv\u2010cnt. [accessed 10 January 2014]."},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1071\/SH10001"},{"key":"e_1_2_12_52_1","unstructured":"National Cervical Screening Program website.National Cervical Screening Program Renewal.2014. Available from:http:\/\/www.cancerscreening.gov.au\/internet\/screening\/publishing.nsf\/Content\/ncsp\u2010renewal#08[accessed 23 May 2014]."},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(13)62218\u20107"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.095"},{"key":"e_1_2_12_55_1","unstructured":"JouraEA VS03\u2010001 study team.Efficacy and immunogenicity of a novel 9\u2010valent HPV L1 virus\u2010like particle vaccine in 16\u2010 to 26\u2010year\u2010old women. Session SS804. Conference abstract. EUROGIN 2013 Nov 3\u20106 Florence Italy pg 102.2013."},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.13.23"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.12.18322"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.1625"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.11.059"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.05.039"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-13-0203"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.95"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e1401"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.04.050"},{"key":"e_1_2_12_65_1","unstructured":"NygardM Kruger KjaerS DillnerJet\u2009al.Long term effectiveness and immunogenicity of Gardasil in the Nordic countries. Session OC 6\u20103. Conference abstract. EUROGIN 2013 Nov 3\u20106 Florence Italy pg 199.2013."},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.18865"}],"container-title":["Journal of Paediatrics and Child Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjpc.12627","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjpc.12627","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jpc.12627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T17:04:44Z","timestamp":1695575084000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jpc.12627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,9]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1111\/jpc.12627"],"URL":"https:\/\/doi.org\/10.1111\/jpc.12627","archive":["Portico"],"relation":{},"ISSN":["1034-4810","1440-1754"],"issn-type":[{"value":"1034-4810","type":"print"},{"value":"1440-1754","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,9]]},"assertion":[{"value":"2014-03-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-06-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}